Multi-omics Insights into PDHA1 as a Predictive Biomarker for Prognosis, Immunotherapy Efficacy, and Drug Sensitivity in Hepatocellular Carcinoma

Multi-omics Insights into PDHA1 as a Predictive Biomarker for Prognosis, Immunotherapy Efficacy, and Drug Sensitivity in Hepatocellular Carcinoma

Saved in:

Bibliographic Details
Main Authors:	Yong Pan, Yiru Zhang, Daiwen Mao, Zhou Fang, Yingqiu Ma, Danwen Jin, Shibo Li
Format:	Article
Language:	English
Published:	American Chemical Society 2024-11-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.4c08010
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of transketolase in the immunotherapy and prognosis of hepatocellular carcinoma: a multi-omics approach
by: Xuan-Yu Gu, et al.
Published: (2025-03-01)

Machine learning-based identification of telomere-related gene signatures for prognosis and immunotherapy response in hepatocellular carcinoma
by: Zhengmei Lu, et al.
Published: (2025-03-01)

Harnessing multi-omics and artificial intelligence: revolutionizing prognosis and treatment in hepatocellular carcinoma
by: Zhen Wang, et al.
Published: (2025-07-01)

and as prognostic biomarkers for prognosis and palindromia of human hepatocellular carcinoma
by: Xin Zhang, et al.
Published: (2017-07-01)

Modulation of copper homeostasis and cuproptosis by PDHA1 in acute myeloid leukemia
by: Tianping Chen, et al.
Published: (2025-06-01)

Prognosis prediction of α-FAtE score for locoregional immunotherapy in hepatocellular carcinoma
by: Zehao Zheng, et al.
Published: (2025-01-01)

Machine learning developed LKB1-AMPK signaling related signature for prognosis and drug sensitivity in hepatocellular carcinoma
by: Wang Li, et al.
Published: (2025-07-01)

Leveraging diverse cell-death patterns to predict to predict prognosis and immunotherapy in hepatocellular carcinoma
by: Xiaoxiang Zhang, et al.
Published: (2025-08-01)

A Lamin Family-Based Signature Predicts Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
by: Yongyu Yang, et al.
Published: (2022-01-01)

A mitochondrial-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma
by: Hongli Shu, et al.
Published: (2025-07-01)

Integrated Multi-Omics Profiling Identifies PDZ-Binding Kinase (PBK) as a Novel Prognostic Biomarker in Hepatocellular Carcinoma
by: Zhang J, et al.
Published: (2025-07-01)

Multi-platform integration of histopathological images and omics data predicts molecular features and prognosis of hepatocellular carcinoma
by: Linyan Chen, et al.
Published: (2025-07-01)

Establishment and evaluation cuproptosis-related gene signature for predicting the prognosis and immunotherapy response of hepatocellular carcinoma
by: Shuo Wang, et al.
Published: (2025-04-01)

An immune-related signature based on molecular subtypes for predicting the prognosis and immunotherapy efficacy of hepatocellular carcinoma
by: Xuhui Sun, et al.
Published: (2025-05-01)

Potential of the use of methylation biomarkers for diagnostics and prognosis of hepatocellular carcinoma in liquid biopsy
by: I. F. Kustova, et al.
Published: (2019-01-01)

DDX21 Is a Potential Biomarker for Predicting Recurrence and Prognosis in Hepatocellular Carcinoma
by: Chengjie Ji, et al.
Published: (2025-01-01)

Future perspectives on immunotherapy for hepatocellular carcinoma
by: Landon L. Chan, et al.
Published: (2025-03-01)

Role of Immunotherapy in the Treatment of Hepatocellular Carcinoma
by: Irina Y. Dobrosotskaya, et al.
Published: (2025-04-01)

Astragaloside IV increases PDHA1 in mesenchymal stem cell exosomes to treat myocardial infarction
by: Sha Zhongxin, et al.
Published: (2025-07-01)

Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma
by: Binghua Li, et al.
Published: (2025-01-01)

The immunosurveillance signature predicts the prognosis and immunotherapy sensitivity for colon adenocarcinoma
by: Yan Xiong, et al.
Published: (2025-06-01)

Integrated multi-omics analysis identifies TPX2 as a potential prognostic and immunological biomarker in hepatocellular carcinoma
by: Hui Peng, et al.
Published: (2025-09-01)

Cholangiocarcinoma PDHA1 succinylation suppresses macrophage antigen presentation via alpha-ketoglutaric acid accumulation
by: Ning Zhang, et al.
Published: (2025-04-01)

Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma
by: So Young Yoo, et al.
Published: (2017-01-01)

A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma
by: Jianlin Zhu, et al.
Published: (2023-01-01)

A Novel Signature Composed of Hypoxia, Glycolysis, Lactylation Related Genes to Predict Prognosis and Immunotherapy in Hepatocellular Carcinoma
by: Feng Yi, et al.
Published: (2025-04-01)

A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma
by: Zhang Z, et al.
Published: (2025-04-01)

Exploring program-cell death patterns to predict prognosis and sensitivity of cervical cancer immunotherapy via multi-omics analysis and clinical samples
by: Chunhong Pang, et al.
Published: (2025-05-01)

An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma
by: Pattaya Seeree, et al.
Published: (2015-01-01)

WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy
by: Min Xu, et al.
Published: (2024-11-01)

Evaluation of serum hsa_tsr014055 as a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma
by: Jing Xu, et al.
Published: (2025-12-01)

TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
by: Jin Li, et al.
Published: (2025-01-01)

Multi-omics analysis of bidirectional liquid–liquid phase separation signatures reveals immunotherapy response and prognosis in renal cell carcinoma
by: Zheyu Wang, et al.
Published: (2025-08-01)

Advances in multi-omics studies of microvascular invasion in hepatocellular carcinoma
by: Lili Wang, et al.
Published: (2025-03-01)

Transcriptomic signature in advanced hepatocellular carcinoma tissue to predict combination immunotherapy response: Editorial on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
by: Hiroaki Kanzaki, et al.
Published: (2025-01-01)

Integrated multi-omics analysis and machine learning refine molecular subtypes and clinical outcome for hepatocellular carcinoma
by: Chunhong Li, et al.
Published: (2025-04-01)

FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma
by: Shaobo Wu, et al.
Published: (2022-01-01)

FCN3 Can Serve as A Potential Biomarker for Prognosis and  Immunotherapy of Lung Squamous Cell Carcinoma
by: Wei LI, et al.
Published: (2025-02-01)

Dissecting the multi-omics landscape of TEAD1 in hepatocellular carcinoma: cycle regulation and metastatic potential
by: Ruiping Huai, et al.
Published: (2025-06-01)

Correction: TERT-TP53 mutations: a novel biomarker pair for hepatocellular carcinoma recurrence and prognosis
by: Jin Li, et al.
Published: (2025-06-01)